Journey Medical Corporation
- DERM
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Dermatology Pharmaceuticals
$5.26
Today +5.94%Quote Oct 19, 2026, 06:40 PM UTC
−32.47%over the last month
Max drawdown −32.5%From 1-month high −32.5%3 months −29.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Journey Medical
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States.
Where the money comes from
Q2 2026 revenue $18.5M
- Qbrexza$5.1M27.6%
- Accutane$3.4M18.1%
- Other / not reported$10.0M54.2%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
58
Market value
$148.5M
Quote Oct 19
Floor
$5.05
4.0% below price
Resistance
$5.47
4.0% above price
Price vs analyst targets
3 analysts
Lowest target
$10.50Highest target
$13.00
$10.50Highest target
$13.00
- Price $5.26
- Average target $11.75
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 123% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DERMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free